If you’d like an LLM to act more like a partner than a tool, Databot is an experimental alternative to querychat that also works in both R and Python. Databot is designed to analyze data you’ve ...

Data brokers can track your online activity and put your personal information at risk. Learn how to remove your data, and ...

A team of computer scientists at UC Riverside has developed a method to erase private and copyrighted data from artificial intelligence models—without needing access to the original training data.

Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or watching a ...

A new study finds that technologies installed to remove forever chemicals from drinking water are also doing double-duty by removing harmful other materials—including some substances that have been ...

Cybersecurity company Zscaler warns it suffered a data breach after threat actors gained access to its Salesforce instance and stole customer information, including the contents of support cases. This ...

Zscaler confirms losing sensitive customer data from its account The attackers moved in after compromising Salesloft's Drift platform Some believe this was done by ShinyHunters We can now add Zscaler ...

Cloudflare Inc., Zscaler Inc. and Palo Alto Networks Inc. have become the latest companies to be affected by the Salesloft breach, a widespread Salesforce Inc.-related security incident that has been ...

Australia’s Online Safety Amendment Act provides the chance for researchers to analyse the complex relationship between social-media use and mental health in adolescents, but results should be ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up for Dispatches, a newsletter that spotlights wrongdoing around the country, to receive our stories in your inbox every ...

Intellia has reported results from a phase 2 trial of its gene-editing drug for hereditary angioedema (HAE) that it says build the case for the drug as a phase 3 trial gets underway – but its shares ...